8-K/A: NewMarket Corporation Completes Acquisition of AMPAC, Files Pro Forma Financials

Sentiment:

Acquisition Pro Forma Financials


NewMarket Corporation has finalized its acquisition of AMPAC Intermediate Holdings, LLC and released pro forma financial statements reflecting the combined entity.

Capital raiseNewMarket borrowed approximately $690 million to finance the acquisition of AMPAC.The company entered into a new $900 million revolving credit facility and a $250 million term loan on January 22, 2024.

Summary

  • NewMarket Corporation completed the acquisition of AMPAC Intermediate Holdings, LLC on January 16, 2024.
  • The purchase price of approximately $700 million was funded through cash on hand and $690 million in borrowings.
  • This amendment to the original 8-K filing includes audited financial statements for AMPAC as of September 30, 2023, and unaudited pro forma combined financials as of December 31, 2023.
  • The pro forma financials are for informational purposes and do not represent actual results or future performance.
  • AMPAC's audited financials show a net income of $3.281 million for the year ended September 30, 2023, with total assets of $517.918 million.
  • The pro forma combined statement of income for 2023 shows net sales of $2,822.414 million and a net income of $368.327 million.
  • The pro forma combined balance sheet as of December 31, 2023, shows total assets of $3,136.630 million.
  • NewMarket also entered into a new $900 million revolving credit facility and a $250 million term loan on January 22, 2024.

Sentiment

Score: 7

Explanation: The document presents a significant acquisition with positive pro forma results, but also highlights increased debt and integration risks. The sentiment is moderately positive, reflecting the strategic move but acknowledging potential challenges.

Positives

  • The acquisition of AMPAC expands NewMarket's business and market presence.
  • The pro forma financials indicate a significant increase in net sales and total assets for the combined entity.
  • NewMarket has secured new financing with a $900 million revolving credit facility and a $250 million term loan.
  • The acquisition was completed on a cash-free, debt-free basis for AMPAC.

Negatives

  • The pro forma financials are based on estimates and may not reflect actual future results.
  • The acquisition involved significant borrowings, increasing NewMarket's debt.
  • The integration of AMPAC may present challenges and require additional costs.
  • The pro forma adjustments include a $23.818 million reduction to net income.

Risks

  • The pro forma financial information is not necessarily indicative of future performance.
  • The integration of AMPAC's operations may be complex and could lead to unforeseen challenges.
  • The increased debt from the acquisition could impact NewMarket's financial flexibility.
  • The final purchase price allocation and fair value assessments are still preliminary and subject to change.

Future Outlook

The pro forma financial information is for illustrative purposes only and is not necessarily indicative of the financial condition or results of operations of future periods or the financial condition or results of operations that would have been realized had the entities been a single entity as of or for the period presented.

Industry Context

This acquisition reflects a trend of consolidation within the specialty chemicals and materials industry, where companies seek to expand their product portfolios and market reach through strategic mergers and acquisitions.

Comparison to Industry Standards

  • NewMarket's acquisition of AMPAC is a significant transaction in the specialty chemicals sector, comparable to other large acquisitions in the industry such as the merger of DuPont and Dow Chemical.
  • The pro forma combined revenue of $2.822 billion places the combined entity among the larger players in the specialty chemicals market, similar to companies like Albemarle Corporation and FMC Corporation.
  • The debt financing of $690 million is typical for acquisitions of this size, and the new credit facilities provide NewMarket with financial flexibility, similar to how other large chemical companies manage their capital structure.
  • The focus on perchlorates and other specialty chemicals positions NewMarket in a niche market, similar to companies that focus on specific chemical applications such as aerospace and defense.

Related Party Transactions

  • The document mentions related party notes receivable of $6.5 million with accrued interest of $165 as of September 30, 2023, which were eliminated upon acquisition.

Stakeholder Impact

  • Shareholders will see an increase in the company's size and market presence.
  • Employees of both NewMarket and AMPAC will be affected by the integration process.
  • Customers will have access to a broader range of products and services.
  • Creditors will be impacted by the new debt obligations.

Next Steps

  • NewMarket will finalize the purchase price allocation and fair value assessments.
  • The company will integrate AMPAC's operations into its existing business.
  • NewMarket will manage its new debt obligations and monitor financial performance of the combined entity.

Key Dates

DateDescription
December 1, 2023NewMarket entered into a Securities Purchase Agreement with Coyote and AMPAC.
January 16, 2024NewMarket completed the acquisition of AMPAC.
January 22, 2024NewMarket entered into a new $900 million revolving credit facility and a $250 million term loan.
February 28, 2024The amended 8-K filing with pro forma financials was released.

Keywords

acquisition, pro forma, financial statements, AMPAC, NewMarket Corporation, merger, debt, revolving credit facility, term loan, financial results

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.